These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7901166)

  • 1. An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major.
    Kimsey PB; Theodos CM; Mitchen TK; Turco SJ; Titus RG
    Infect Immun; 1993 Dec; 61(12):5205-13. PubMed ID: 7901166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania major: nature of immunity induced by immunization with a mutagenized avirulent clone of the parasite in mice.
    McGurn M; Boon T; Louis JA; Titus RG
    Exp Parasitol; 1990 Jul; 71(1):81-9. PubMed ID: 1972362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immunological memory state generated in mice susceptible to Leishmania major following exposure to low doses of L. major and resulting in resistance to a normally pathogenic challenge.
    Menon JN; Bretscher PA
    Eur J Immunol; 1996 Jan; 26(1):243-9. PubMed ID: 8566074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with phosphoglycan-deficient Leishmania major protects highly susceptible mice from virulent challenge without inducing a strong Th1 response.
    Uzonna JE; Späth GF; Beverley SM; Scott P
    J Immunol; 2004 Mar; 172(6):3793-7. PubMed ID: 15004184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.
    Daneshvar H; Burchmore R; Hagan P; Phillips RS
    Parasitology; 2009 Sep; 136(11):1243-50. PubMed ID: 19646303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.
    Lang T; Courret N; Colle JH; Milon G; Antoine JC
    Infect Immun; 2003 May; 71(5):2674-83. PubMed ID: 12704142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with Leishmania major exogenous antigens protects susceptible BALB/c mice against challenge infection with L. major.
    Tonui WK; Mejia JS; Hochberg L; Mbow ML; Ryan JR; Chan AS; Martin SK; Titus RG
    Infect Immun; 2004 Oct; 72(10):5654-61. PubMed ID: 15385463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
    Courret N; Lang T; Milon G; Antoine JC
    Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with plasmid DNA encoding TSA/LmSTI1 leishmanial fusion proteins confers protection against Leishmania major infection in susceptible BALB/c mice.
    Campos-Neto A; Webb JR; Greeson K; Coler RN; Skeiky YA; Reed SG
    Infect Immun; 2002 Jun; 70(6):2828-36. PubMed ID: 12010969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb.
    Ferlin WG; von der Weid T; Cottrez F; Ferrick DA; Coffman RL; Howard MC
    Eur J Immunol; 1998 Feb; 28(2):525-31. PubMed ID: 9521062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an I-E-restricted, gp63-specific, CD4-T-cell clone from Leishmania major-resistant C3H mice that secretes type 2 cytokines and exacerbates infection with L. major.
    Theodos CM; Morris RV; Bishop JV; Jones JD; McMaster WR; Titus RG
    Infect Immun; 2004 Aug; 72(8):4486-93. PubMed ID: 15271907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Leishmania major infection in genetically susceptible BALB/c mice by gp63 delivered orally in attenuated Salmonella typhimurium (AroA- AroD-).
    Xu D; McSorley SJ; Chatfield SN; Dougan G; Liew FY
    Immunology; 1995 May; 85(1):1-7. PubMed ID: 7635511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective immunity against Leishmania major induced by Leishmania tropica infection of BALB/c mice.
    Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
    Exp Parasitol; 2011 Feb; 127(2):448-53. PubMed ID: 21035446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis.
    Walker PS; Scharton-Kersten T; Rowton ED; Hengge U; Bouloc A; Udey MC; Vogel JC
    Hum Gene Ther; 1998 Sep; 9(13):1899-907. PubMed ID: 9741428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.
    Handman E; Symons FM; Baldwin TM; Curtis JM; Scheerlinck JP
    Infect Immun; 1995 Nov; 63(11):4261-7. PubMed ID: 7591056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.